VC Experts Releases 2010 IT/Software and Life Science Valuation Report

Share Article

Average Company Valuation for Both Industries Above $70 million; Deal Terms More Favorable

VC, Inc. ( today announced the release of its' 2010 Deal Activity and Valuations report covering venture capital investments from the Information Technology/Software and Life Science Industries.

VC analyzed the valuations of private companies after they had secured new funding during 2010. Additionally, the specific terms & conditions surrounding the issuance of preferred securities for the private companies were researched. The valuations of the companies analyzed in this report varied within both industries, with the average valuation above $70 million for both groups. For IT/Software companies, the average valuation over the past 12 months was $122.4 million, while average Life Science valuations were $70.2 million. Specifically in the IT/Software group, one of the lowest valuations analyzed was $3.5 million from Austin, Texas-based Edioma, Inc., and the highest valuation analyzed came in at $4.07 billion from, Zynga, Inc. In Life Science, Portland, Oregon-based pharmaceutical research company, DesignMedix Inc., held one of the lowest valuations in the sector with $3.6 million, while Ceres, Inc., a biotechnology firm focusing on plant genomics, saw one of the highest valuations in the sector at $390 million.

"Over the last 10+ years, IT/Software along with Life Science deals have represented a significant portion of VC investments. Through our analysis over the years of thousands of these investment deals, we have seen that certain factors can play a part in determining the use of which deal terms or conditions might be used in these private transactions. Some of these factors can be industry and/or region, as seen in this latest report", says Justin Byers, Head of Business Intelligence for VC

The full report is available at

About VC
VC maintains the largest database of privately held company valuations commercially available. Through a unique research process of analyzing state & federal regulatory filings of private companies, VC Experts is the only research provider to reveal the specific terms & conditions of a private company's financing event. VC Experts provides specialized content on the private equity & venture capital fundraising process, valuation & deal term data on thousands of private companies, and analytics for managing and modeling private company capital structures. For more information, please visit or call (646) 290-9254.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

J. Michael Ostendorff
Visit website